Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.25 is 66% below its 5-year average of 3.71, near the low end of its 5-year range (1.03–8.29).
As of the fiscal period ended Tuesday, June 30, 2026. 42.08% below its 12-month average of 2.17.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.25.
CURRENT RATIO
1.25
CURRENT RATIO AVG TTM
2.17
CURRENT RATIO AVG 3Y
2.35
CURRENT RATIO AVG 5Y
3.71
CURRENT RATIO AVG 10Y
3.82
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-42.08%
CURRENT VS 3Y AVG
-46.58%
CURRENT VS 5Y AVG
-66.17%
CURRENT VS 10Y AVG
-67.18%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 638 covered companies
CURRENT VS SECTOR MEDIAN
-63.04%
vs the sector median at left
Market Cap
$172.18M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$177.78M
Current Ratio
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
Market Cap
$179.09M
Current Ratio
1.59
TTM Avg
1.58
3Y Avg
1.42
5Y Avg
1.43
Market Cap
$168.56M
Current Ratio
3.52
TTM Avg
3.66
3Y Avg
3.27
5Y Avg
3.06
Market Cap
$180.85M
Current Ratio
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $173.89M | 1.25 | 2.17 | 2.35 | 3.71 |
| MediWound Ltd. (MDWD)vs › | $172.77M | 2.32 | 2.15 | 3.17 | 2.88 |
| Precision BioSciences, Inc. (DTIL)vs › | $172.18M | 12.82 | 9.83 | 6.43 | 5.45 |
| Nkarta, Inc. (NKTX)vs › | $172.07M | 7.98 | 13.57 | 13.59 | 18.24 |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.78M | 11.22 | 14.99 | 15.44 | 13.43 |
| OptimizeRx Corp. (OPRX)vs › | $169.41M | 5.58 | 2.96 | 5.18 | 6.05 |
| Journey Medical Corporation (DERM)vs › | $179.09M | 1.59 | 1.58 | 1.42 | 1.43 |
| Organogenesis Holdings Inc. (ORGO)vs › | $168.56M | 3.52 | 3.66 | 3.27 | 3.06 |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.85M | 15.70 | 3.42 | 4.67 | 3.16 |
| Coherus Oncology, Inc. (CHRS)vs › | $165.32M | 1.77 | 1.33 | 1.71 | 2.63 |
Current Ratio
1.25
Quick Ratio
1.25
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.25 |
| 2026-03-31 | 3.57 |
| 2025-12-31 | 2.74 |
| 2025-09-30 | 1.66 |
| 2025-06-30 | 1.60 |
| 2025-03-31 | 1.03 |
| 2024-12-31 | 1.84 |
| 2024-09-30 | 2.22 |
| 2024-06-30 | 2.06 |
| 2024-03-31 | 2.47 |
| 2023-12-31 | 3.01 |
| 2023-09-30 | 3.34 |
| 2023-06-30 | 3.74 |
| 2023-03-31 | 4.98 |
| 2022-12-31 | 6.68 |
| 2022-09-30 | 6.04 |
| 2022-06-30 | 8.29 |
| 2022-03-31 | 6.66 |
| 2021-12-31 | 5.35 |
| 2021-09-30 | 4.58 |
| 2021-06-30 | 4.78 |
| 2021-03-31 | 4.65 |
| 2020-12-31 | 5.36 |
| 2020-09-30 | 6.58 |
| 2020-06-30 | 5.94 |
| 2020-03-31 | 4.23 |
| 2019-12-31 | 5.24 |
| 2019-09-30 | 3.17 |
| 2019-06-30 | 2.65 |
| 2019-03-31 | 3.02 |
| 2018-12-31 | 6.53 |
| 2018-09-30 | 8.86 |
| 2018-06-30 | 16.62 |
| 2018-03-31 | 13.69 |
| 2017-12-31 | 12.17 |
| 2017-09-30 | 2.16 |
| 2017-06-30 | 5.17 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 14.18 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
